Efficacy and Tolerability of a Novel Topical Treatment Containing Pea Protein and Xyloglucan in the Management of Atopic Dermatitis in Children: A Prospective, Multicenter Clinical Study

Efficacy and Tolerability of a Novel Topical Treatment Containing Pea Protein and Xyloglucan in the Management of Atopic Dermatitis in Children: A Prospective, Multicenter Clinical Study

Abstract Introduction Atopic dermatitis (AD) is a chronic disease that occurs mainly in children. Topical corticosteroids are the main treatment for mild to moderate AD, although they can induce side effects. The efficacy and tolerability of xyloglucan and pea protein (XG-PP) was compared with hydro...

Full description

Bibliographic Details
Main Authors: Mehdi Sowlati, Silviu-Horia Morariu, Olguta Orzan, Stefano Veraldi, Roni P. Dodiuk-Gad, Remus I. Orasan, Cristian Gainaru
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-09-01
Series:Dermatology and Therapy
Subjects:
Atopic dermatitis
Children
Hydrocortisone ointment
Pea protein
Xyloglucan
Online Access:https://doi.org/10.1007/s13555-023-01035-6

Internet

https://doi.org/10.1007/s13555-023-01035-6

Similar Items